JP Morgan Analyst Raises CSX Stock Price Target to $34.00

JP Morgan analyst Brian Ossenbeck has raised the price target for CSX Corp (CSX) from $31 to $34, an increase of 9.68%. The average target price for CSX is $33.67 with a high estimate of $40 and a low estimate of $27. The average brokerage recommendation is 2.2, indicating "Outperform" status. The estimated GF Value for CSX in one year is $35.52, suggesting a 5.78% upside from the current price.

In a significant update for investors, JP Morgan analyst Brian Ossenbeck has raised the price target for CSX Corp (CSX) from $31 to $34, an increase of 9.68%. This revision reflects a growing confidence in the stock's future performance [1].

The average target price for CSX, as per the consensus of 24 analysts, is $33.67, with estimates ranging from a high of $40 to a low of $27. This average target price implies an upside of 0.26% from the current price of $33.58 [1]. Additionally, the average brokerage recommendation for CSX stands at 2.2, indicating an "Outperform" status, with a consensus rating of "Moderate Buy" [1].

GuruFocus estimates the GF Value for CSX in one year to be $35.52, suggesting a potential upside of 5.78% from the current price of $33.58 [1]. This valuation is based on historical trading multiples, past business growth, and future performance estimates.

The recent update from JP Morgan comes amidst a mix of analyst opinions. While some analysts have raised their targets, others have maintained or slightly adjusted their recommendations. For instance, Royal Bank of Canada lowered their price target from $31 to $30, setting a "sector perform" rating, and UBS Group reduced their target from $36 to $34, maintaining a "buy" rating [2].

In the first quarter of 2025, several large investors made notable moves in their CSX holdings. Kintegral Advisory LLC decreased its holdings by 32.9%, while Portside Wealth Group LLC and Ullmann Wealth Partners Group LLC both grew their stakes by 1.3%. Family Legacy Inc. and Patrick M. Sweeney & Associates Inc. also increased their holdings, with Faithward Advisors LLC growing its stake by 1.7% [2].

CSX's recent earnings report showed an EPS of $0.34, missing analysts' consensus estimates by $0.05. The company reported a return on equity of 26.42% and a net margin of 22.66% for the quarter. Revenue for the quarter was $3.42 billion, compared to analyst estimates of $3.53 billion [2].

In summary, the latest update from JP Morgan suggests a bullish outlook for CSX, with a raised price target and a positive consensus rating. However, investors should closely monitor the company's performance and market updates to align with current trends and analyses.

References:
[1] https://www.gurufocus.com/news/2964173/csx-stock-sees-raised-price-target-by-jp-morgan-analyst-csx-stock-news
[2] https://www.marketbeat.com/instant-alerts/filing-csx-corporation-nasdaqcsx-shares-sold-by-kintegral-advisory-llc-2025-07-05/